Klinische Studien zur Angiomatose

Insgesamt 54 ergebnisse

    • NCT00576888
      Abgeschlossen
      Bedingungen: Multifocal Lymphangioendotheliomatosis With Thrombocytopenia; Cutaneovisceral Angiomatosis With Thrombocytopenia; Vascular Anomaly With Thrombocytopenia; Hemangiomas
    • NCT00374335
      Abgeschlossen
      Bedingungen: Hemangioma
    • NCT04458935
      Aktiv, nicht rekrutierend
      Bedingungen: Retinal Hemangioblastoma; Von Hippel-Lindau Disease
    • NCT02859441
      Abgeschlossen
      Bedingungen: Von Hippel-Lindau Syndrome
    • NCT02420067
      Rekrutierung
      Bedingungen: Von Hippel-Lindau Disease
    • NCT03979833
      Anmeldung auf Einladung
      Bedingungen: Von Hippel-Lindau Disease
    • NCT02207686
      Unbekannter Status
      Bedingungen: Von Hippel-Lindaus Disease
    • NCT02108002
      Abgeschlossen
      Bedingungen: Von Hippel-Lindau Disease
    • NCT04735601
      Rekrutierung
      Bedingungen: Glaucoma
    • NCT04717427
      Rekrutierung
      Bedingungen: Sturge-Weber Syndrome
    • NCT01168440
      Abgeschlossen
      Bedingungen: Von Hippel-Lindau Disease
    • NCT04517565
      Rekrutierung
      Bedingungen: Sturge-Weber Syndrome
    • NCT04447846
      Rekrutierung
      Bedingungen: Sturge-Weber Syndrome
    • NCT04344626
      Rekrutierung
      Bedingungen: Epilepsy; Focal Cortical Dysplasia; Tuberous Sclerosis; Hemimegalencephaly; Polymicrogyria; Rasmussen Encephalitis; Sturge-Weber Syndrome; Gliosis; Stroke; Tumor, Brain
    • NCT01015300
      Beendet
      Bedingungen: Hemangioblastomas; Von Hippel Lindau Disease
    • NCT04074135
      Rekrutierung
      Bedingungen: VHL Pancreatic Neuroendocrine Tumors; Von Hippel-Lindau Disease; Neuroendocrine Tumors
    • NCT03907657
      Rekrutierung
      Bedingungen: Von-Hippel Lindau; Kidney Disease, Chronic
    • NCT03749980
      Rekrutierung
      Bedingungen: Von Hippel-Lindau Disease; Hereditary Leiomyomatosis and Renal Cell Cancer; Birt-Hogg-Dube Syndrome; SDHB Gene Mutation
    • NCT03401788
      Aktiv, nicht rekrutierend
      Bedingungen: VHL - Von Hippel-Lindau Syndrome; VHL Gene Mutation; VHL Syndrome; VHL Gene Inactivation; VHL-Associated Renal Cell Carcinoma; VHL-Associated Clear Cell Renal Cell Carcinoma
    • NCT03108066
      Aktiv, nicht rekrutierend
      Bedingungen: VHL Gene Mutation; VHL; VHL Syndrome; VHL Gene Inactivation; Von Hippel; Von Hippel-Lindau Disease; Von Hippel's Disease; Von Hippel-Lindau Syndrome, Modifiers of; Clear Cell Renal Cell Carcinoma; Clear Cell RCC; ccRCC
    • NCT03050268
      Rekrutierung
      Bedingungen: Acute Leukemia; Adenomatous Polyposis; Adrenocortical Carcinoma; AML; BAP1 Tumor Predisposition Syndrome; Carney Complex; Choroid Plexus Carcinoma; Constitutional Mismatch Repair Deficiency Syndrome; Diamond-Blackfan Anemia; DICER1 Syndrome; Dyskeratosis Congenita; Emberger Syndrome; Familial Acute Myeloid Leukemia; Familial Adenomatous Polyposis; Fanconi Anemia; Familial Cancer; Familial Wilms Tumor; Familial Neuroblastoma; GIST; Hereditary Breast and Ovarian Cancer; Hereditary Paraganglioma-Pheochromocytoma Syndrome; Hodgkin Lymphoma; Juvenile Polyposis; Li-Fraumeni Syndrome; Lynch Syndrome; MDS; Melanoma Syndrome; Multiple Endocrine Neoplasia Type 1; Multiple Endocrine Neoplasia Type 2; Neuroblastoma; Neurofibromatosis Type 1; Neurofibromatosis Type II; Nevoid Basal Cell Carcinoma Syndrome; Non Hodgkin Lymphoma; Noonan Syndrome and Other Rasopathy; Overgrowth Syndromes; Pancreatic Cancer; Peutz-Jeghers Syndrome; Pheochromocytoma/Paraganglioma; PTEN Hamartoma Tumor Syndrome; Retinoblastoma; Rhabdoid Tumor Predisposition Syndrome; Rhabdomyosarcoma; Rothmund-Thomson Syndrome; Tuberous Sclerosis; Von Hippel-Lindau Disease
    • NCT03047980
      Aktiv, nicht rekrutierend
      Bedingungen: Sturge-Weber Syndrome
    • NCT03001349
      Beendet
      Bedingungen: Meningioma; Metastatic Well Differentiated Neuroendocrine Neoplasm; Multiple Endocrine Neoplasia Type 1; Neuroendocrine Neoplasm; Somatostatin Positive Neoplastic Cells Present; Von Hippel-Lindau Syndrome
    • NCT03001180
      Rekrutierung
      Bedingungen: Vascular Anomaly; Generalized Lymphatic Anomaly; Kaposiform Hemangioendothelioma; Kaposiform Lymphangiomatosis; Gorham-Stout Disease; Klippel Trenaunay Syndrome; Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi
    • NCT02399527
      Rekrutierung
      Bedingungen: Lymphatic Malformation; Generalized Lymphatic Anomaly (GLA); Central Conducting Lymphatic Anomaly; CLOVES Syndrome; Gorham-Stout Disease ("Disappearing Bone Disease"); Blue Rubber Bleb Nevus Syndrome; Kaposiform Lymphangiomatosis; Kaposiform Hemangioendothelioma/Tufted Angioma; Klippel-Trenaunay Syndrome; Lymphangiomatosis